Blog
The Complete Tirzepatide Dosage Chart 2026 (With Calculator)
Tirzepatide dosage starts at 2.5mg once a week for four weeks and climbs 2.5mg every four weeks to a maintenance dose of 5, 10 or 15mg. From a 10mg vial mixed with 2.4mL of bacteriostatic water, 2.5mg is 60 units on a U-100 insulin syringe, and matching each step to its vial keeps every draw at 60 units or less.
A syringe measures volume, so the units a dose takes depend on the water added to the freeze-dried powder. Every figure below is worked for the vial sizes Simms Research sells its tirzepatide in: 10, 20, 30 and 60mg.
Tirzepatide Dosage Calculator
Set the vial size, the water and the weekly dose to get the draw in syringe units. It opens on the first step, a 10mg vial with 2.4mL and 2.5mg: 60 units.
Tirzepatide Dosage Chart and Dosing Schedule
This is the schedule from every phase 3 trial and both labels, with each vial mixed with 2.4mL of bacteriostatic water.
| Weeks | Weekly dose | Role | Vial | Units |
|---|---|---|---|---|
| 1–4 | 2.5mg | Starting dose | 10mg | 60 |
| 5–8 | 5mg | Maintenance option | 20mg | 60 |
| 9–12 | 7.5mg | Step up | 30mg | 60 |
| 13–16 | 10mg | Maintenance option | 60mg | 40 |
| 17–20 | 12.5mg | Step up | 60mg | 50 |
| 21 onward | 15mg | Maximum dose | 60mg | 60 |
Each step lasts at least four weeks, each increase is 2.5mg, and 2.5mg is for starting, not staying on. The maintenance dose is 5, 10 or 15mg, chosen on response and tolerability (Zepbound label, FDA, 2026), and holding a step longer while nausea settles is within the label. The dose doesn’t scale with body weight.
How Tirzepatide Works and Why It Is Dosed Weekly
Tirzepatide is a 39-amino-acid peptide that activates two receptors, GIP and GLP-1, both found in the brain areas that set appetite. A C20 fatty-acid chain holds it on albumin, the main blood protein, slowing clearance to a half-life of about five days, so one injection under the skin covers a week (Mounjaro label, FDA, 2026). Levels peak 8 to 72 hours after the injection, and the abdomen, thigh and upper arm give the same exposure.
The balance tilts toward GIP. Tirzepatide binds the GIP receptor about as strongly as natural GIP, and the GLP-1 receptor about five times more weakly than natural GLP-1 (Coskun, Molecular Metabolism, 2018). In the pancreas it raises insulin and lowers glucagon only when blood sugar is high.
Because most of each dose is still circulating seven days later, weekly injections stack: the first reaches about 62% of the level that dose will hold, the second 86%, the third 95% and the fourth 98%. That is why each dose is held for four weeks, why a late injection barely matters and why a long break sends the ladder back down.
What Each Tirzepatide Dose Did in the Trials
SURMOUNT-1 is the cleanest comparison of doses: 2,539 adults with obesity and without diabetes, averaging 104.8kg (231 lbs), given the same fixed 5, 10 or 15mg or placebo for 72 weeks. Average weight change was −15.0%, −19.5% and −20.9%, against −3.1% on placebo, and 85%, 89% and 91% lost at least 5%, against 35% (Jastreboff, New England Journal of Medicine, 2022).
The curve bends early: 5 to 10mg was worth 4.5 more points, 10 to 15mg only 1.4. Half the 10mg group and 57% of the 15mg group lost a fifth of their weight or more, against 3% on placebo.
With type 2 diabetes the same doses do less: 12.8% on 10mg and 14.7% on 15mg in SURMOUNT-2 (Garvey, The Lancet, 2023). After a 12-week diet and exercise program had already taken off 5% or more, the highest tolerated dose took off a further 18.4% in SURMOUNT-3, while placebo regained 2.5% (Wadden, Nature Medicine, 2023).
Is 2.5mg of tirzepatide enough to lose weight?
It isn’t built to be. 2.5mg lets the stomach adjust while the level is still rising, and no phase 3 trial kept anyone on it; the weight loss came from the maintenance doses.
Why am I not losing weight on tirzepatide yet?
A slow start is common and usually temporary. In an analysis of 1,545 SURMOUNT-1 participants, 18% had lost under 5% by week 12; by week 72, 90% of them had passed 5%, finishing at 8.3%, 11.4% and 13.6% on 5, 10 and 15mg (Ard, Diabetes, Obesity and Metabolism, 2025).
Tirzepatide Titration: Why the Dose Climbs Every Four Weeks
Lilly tried faster climbs first. In the 2018 phase 2 trial, the 15mg group got there in six weeks and 66% had a digestive side effect. A 2020 study took eight weeks, with 36 to 39% nausea. SURMOUNT-1 took 20 weeks, and 31% had nausea at 15mg, against 9.5% on placebo.
The 2020 study’s authors concluded that lower starting doses and smaller increases gave the better side-effect profile, and that set the phase 3 schedule.
Four weeks also matches the pharmacology: a dose takes about four weekly injections to reach its steady level, so each step is judged at the level it will hold. The stomach slowing behind most nausea is largest after the first dose and then fades (Mounjaro label, FDA, 2026).

Tirzepatide Dosage by Research Goal
Weight-loss protocols aim for 10 or 15mg, where the curve flattens, and a subject who struggles at 12.5mg is held at 10mg. Glucose work uses the whole range: in SURPASS-2, 5, 10 and 15mg lowered HbA1c by 2.01, 2.24 and 2.30 points over 40 weeks, against 1.86 on semaglutide 1mg (Frías, New England Journal of Medicine, 2021).
Tirzepatide Maintenance Dose
Two trials changed only the dose after the weight came off. In SURMOUNT-4, 670 adults who had lost 20.9% on 10 or 15mg either kept the dose and lost a further 5.5% over a year, or switched to placebo and regained 14.0% (Aronne, JAMA, 2024). SURMOUNT-MAINTAIN moved 378 adults, after 60 weeks, to their full dose, 5mg or placebo for 52 weeks, and total loss at week 112 was 21.9%, 16.6% and 9.9% (Horn, The Lancet, 2026).
On 5mg, 25% regained half or more of their loss, against 8% on the full dose and 67% on placebo. The full dose holds all of the loss, 5mg most of it.
Tirzepatide Every 10 Days, Every Other Week or Twice a Week
No trial has tested stretched schedules, but the half-life shows what each does. Every 10 days lowers the average level by about 30% and widens the swing from peak to low from 2.6 to 1 to 4 to 1; every 14 days halves the average, at 7 to 1.
So 10mg every other week averages the same as 5mg weekly, the dose SURMOUNT-MAINTAIN tested, with deeper lows. Twice a week at half the dose keeps the average and narrows the swing to 1.6 to 1. The label’s one firm limit is 72 hours between injections.
Injection Timing, Missed Doses and Protocol Length
A missed dose can go in up to four days (96 hours) late (Zepbound label, FDA, 2026). Past that, let it go and inject on the regular day, with no double dose to catch up. The injection day can move as long as two doses are at least three days (72 hours) apart.
The half-life explains the four-day allowance. Four extra days take the level to about 57% of its usual low point; two missed doses take it to about a seventh, near where 2.5mg began, which is why protocols restart at 2.5 or 5mg after a gap of two to three weeks.
Time of day and meals don’t matter. Tirzepatide isn’t cycled like short peptides: the climb alone takes 20 weeks and the trials ran 40 to 72. After the last dose, five half-lives, about 25 days, bring the level down to around 3%.
Tirzepatide Microdosing Chart
Microdosing means weekly doses under the 2.5mg start, usually 0.5 to 2mg, for maintenance, appetite control or a gentler climb. A 10mg vial mixed with 1mL gives 10mg per mL, where units read straight off the dose: 0.5mg is 5 units, 1mg is 10, 1.5mg is 15 and 2mg is 20. From a 60mg vial mixed with 2.4mL the same doses are 2 to 8 units, too small to read cleanly.
One trial arm sits in that range. In the 2018 phase 2 trial, 1mg a week for 26 weeks lowered HbA1c by 1.06 points in type 2 diabetes, close to the 1.21 from dulaglutide 1.5mg. Weight barely moved: 0.9kg, against 0.4kg on placebo and 4.8kg on 5mg. At 1mg, blood sugar responded and body weight largely didn’t.
At 1mg a week a 10mg vial holds ten doses, twice what the 28-day window covers once mixed.
Tirzepatide Dosage in Units
100 units on a U-100 syringe is 1mL. Divide the vial’s milligrams by the water for the mg per mL, then divide the dose by that and multiply by 100 for the units. The peptide calculator does it for any mix.
The 60-Unit Method
Lilly’s own multi-dose vials hold 2.4mL, four doses of 0.6mL, from the 10mg vial’s four 2.5mg doses to the 60mg vial’s four 15mg doses (Mounjaro label, FDA, 2026). Mixing a research vial with 2.4mL gives the same strengths, the method behind the chart at the top: the draw stays near 60 units and the vial changes with the step.
Tirzepatide Units Chart by Vial and Water
Any other mix works; the strength sets the units. 2mL in the 10mg vial makes 5mg per mL. 1mL in the 10mg, 2mL in the 20mg or 3mL in the 30mg makes 10mg per mL. The 60mg vial makes 20mg per mL with 3mL and 25mg per mL with 2.4mL.
| Weekly dose | Units at 5mg/mL | At 10mg/mL | At 20mg/mL | At 25mg/mL |
|---|---|---|---|---|
| 0.5mg | 10 | 5 | 2.5 | 2 |
| 1mg | 20 | 10 | 5 | 4 |
| 2mg | 40 | 20 | 10 | 8 |
| 2.5mg | 50 | 25 | 12.5 | 10 |
| 5mg | 100 | 50 | 25 | 20 |
| 7.5mg | Over 100 | 75 | 37.5 | 30 |
| 10mg | Over 100 | 100 | 50 | 40 |
| 12.5mg | Over 100 | Over 100 | 62.5 | 50 |
| 15mg | Over 100 | Over 100 | 75 | 60 |
Tirzepatide 60mg Vial Dosage Chart (3mL)
At 20mg per mL each unit holds 0.2mg, so 62.5 units is the 12.5mg step. Mixed with 2mL instead, at 30mg per mL, 15mg is 50 units.
To mix, let the vial and the water reach room temperature, run the water down the inside of the glass and swirl gently until clear. Once mixed, the vial stays refrigerated, between 2 and 8°C, and is used within 28 days. Bacteriostatic water comes from Simms in 10mL vials, and How Long Does Tirzepatide Last in the Fridge? covers storage.
How Many Weeks Each Tirzepatide Vial Lasts
A four-week step is four doses and a mixed vial keeps 28 days, so each step gets the vial those doses empty: 10mg for weeks 1 to 4 at $65, 20mg for weeks 5 to 8 at $95, 30mg for weeks 9 to 12 at $155, and 60mg at $186 for each four weeks after.
The first 20 weeks take 150mg of tirzepatide across five vials, $687 at shelf prices, or 5% less bought together; at 15mg, a 60mg vial is about $46.50 a week. At 2.5mg a 60mg vial would hold 24 doses, which is why the first month belongs to the 10mg vial.
Tirzepatide vs Semaglutide and Retatrutide
Semaglutide climbs from 0.25 to 2.4mg over 16 weeks, and its milligrams don’t convert to tirzepatide’s. Head to head, tirzepatide came out ahead: in SURPASS-2 every dose beat semaglutide 1mg on weight, 7.6 to 11.2kg against 5.7kg, and in SURMOUNT-5 the highest tolerated doses gave −20.2% against −13.7% (Aronne, New England Journal of Medicine, 2025).
Retatrutide adds a third receptor, glucagon, and reached 24.2% at 12mg over 48 weeks in phase 2 (Jastreboff, New England Journal of Medicine, 2023). The retatrutide dosage guide and the retatrutide vs tirzepatide comparison cover its schedule.
Switching From Semaglutide to Tirzepatide
Zepbound’s label advises against combining the two. A 2025 study of 15 people switching from semaglutide 1mg restarted everyone at 2.5mg; those who reached 10mg lowered HbA1c by 0.7 points within three months, while the 7.5mg group showed no significant change.
What Researchers Pair With Tirzepatide
Pairings target lean mass. In the SURMOUNT-1 body-composition substudy, fat mass fell 33.9% and lean mass 10.9%, so about a quarter of the weight lost was lean tissue, the same share as on placebo (Look, Diabetes, Obesity and Metabolism, 2025). Protocols that guard muscle add CJC-1295 with ipamorelin daily at bedtime, and some add BPC-157 at 250 to 500mcg a day for its gut-protective animal data.
Tirzepatide Side Effects by Dose
Stomach effects are what limit the dose. Over 72 weeks of SURMOUNT-1, nausea reached 24.6%, 33.3% and 31.0% on 5, 10 and 15mg, against 9.5% on placebo, and vomiting 8.3%, 10.7% and 12.2%, against 1.7%. Most cases were mild to moderate and came during the climb, and 4.3%, 7.1% and 6.2% left the trial over side effects, against 2.6% (Jastreboff, New England Journal of Medicine, 2022).
The label adds a boxed warning for thyroid C-cell tumors seen in rats, and warnings for pancreatitis, gallbladder disease and kidney injury from dehydration. What Are the Side Effects of Tirzepatide? has the full rates, with separate guides on fatigue and hair loss.
Common Tirzepatide Dosing Errors
The costliest is carrying a units figure from one vial to another: 60 units is 2.5mg from a 10mg vial mixed with 2.4mL and 15mg from a 60mg vial mixed the same way. Next come starting above 2.5mg, which no SURMOUNT arm did; stepping up every two weeks, on a level still rising; doubling after a missed week; and a mixed vial left out of the fridge or kept past 28 days.

Tirzepatide Lab Results by Batch
Every figure above assumes the label is right. Simms Research has published two tirzepatide batches, both 10mg vials tested by an independent ISO-certified lab. TZ198, tested June 25, 2026, measured 10.79mg. 2026-TZ295, tested July 16, 2026, came in at 10.57mg, the mean of three vials, so a 60-unit draw from it, mixed with 2.4mL, holds about 2.64mg. It measured 99.777% purity, with identity confirmed by LC-MS and clean endotoxin, heavy-metal and sterility results.
Not every vial on the market clears that bar. Between July 10 and September 20, 2026, 200 tirzepatide samples from 99 sellers went through independent testing, and 58 failed. 39 of those failed the identity test, meaning the lab could not confirm the peptide in the vial was tirzepatide. Most of the rest fell below a 99.5% purity threshold, and five were more than 35% off the labeled amount.
How to Read a Peptide Certificate of Analysis covers the certificate lines a dose depends on, and each Simms Research batch is posted on the tirzepatide lab results page.
Frequently Asked Questions
How many units is 2.5mg of tirzepatide?
60 units from a 10mg vial mixed with 2.4mL, 25 units at 10mg per mL and 50 units at 5mg per mL.
How many units is 5mg of tirzepatide?
60 units from a 20mg vial mixed with 2.4mL, 50 units at 10mg per mL, and 25 units from a 60mg vial mixed with 3mL.
How many mg is 40 units of tirzepatide?
10mg from a 60mg vial mixed with 2.4mL, 8mg at 20mg per mL, 4mg at 10mg per mL and 2mg at 5mg per mL.
How much tirzepatide is 62 units?
12.4mg from a 60mg vial mixed with 3mL, 6.2mg at 10mg per mL and 3.1mg at 5mg per mL.
How long does a 30mg vial of tirzepatide last?
Four weeks at 7.5mg a week, the step it is sized for. At 5mg it holds six doses, one more than 28 days covers.
How long does a 60mg vial of tirzepatide last?
Four weeks at 15mg a week. At 10mg it holds six doses, one more than a mixed vial’s 28 days covers.
What is the maximum dose of tirzepatide?
15mg once a week for adults, the top of every phase 3 trial and both labels, and 10mg for children 10 and older on Mounjaro.
Is Zepbound dosing the same as Mounjaro dosing?
Yes: the same 2.5mg start, steps and 15mg ceiling. Mounjaro is raised only when blood sugar needs more control.
Is tirzepatide from Simms Research for human use?
No. Simms Research sells tirzepatide for laboratory research use only.